VENDAJE®
Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers)
Key Facts
About BioStem Technologies
BioStem Technologies is a commercial-stage regenerative medicine company focused on developing and manufacturing placental-derived allografts for advanced wound care. Its core achievement is the proprietary BioRetain® processing platform, which aims to preserve the native biological structure and signaling factors of perinatal tissue, differentiating its VENDAJE® product family in the competitive biologics market. The company's strategy hinges on vertical integration from donor sourcing to commercialization, rigorous quality control, and a planned uplisting to Nasdaq to enhance its financial profile and attract institutional investment. Near-term execution depends on successful regulatory navigation for its Form 10 and commercial expansion in the wound care sector.
View full company profile